Exploring the Underlying Mechanisms Linking Adiposity and Cardiovascular Disease: A Prospective Cohort Study of 404,332 UK Biobank Participants.


Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 14 03 2023
accepted: 21 03 2023
medline: 19 6 2023
pubmed: 3 4 2023
entrez: 2 4 2023
Statut: ppublish

Résumé

Obesity is causally associated with multiple cardiovascular outcomes but effective population measure to control obesity is limited. This study aims to decipher to which extent excess atherosclerotic cardiovascular diseases (ASCVD) and heart failure (HF) risk due to obesity can be explained by conventional risk factors. This is a prospective cohort study of 404,332 White UK Biobank participants. Participants with prior CVDs or other chronic diseases at baseline, or body mass index <18.5 kg/m

Identifiants

pubmed: 37004891
pii: S0146-2806(23)00132-9
doi: 10.1016/j.cpcardiol.2023.101715
pii:
doi:

Substances chimiques

Glycated Hemoglobin 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101715

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Ziyi Zhou (Z)

School of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Solange Parra-Soto (S)

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; Department of Nutrition and Public Health, Universidad del Bío-Bío, Chillan, Chile.

Jirapitcha Boonpor (J)

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; Faculty of Public Health, Chalermphrakiat Sakon Nakhon Province Campus, Kasetsart University, Sakon Nakhon, Thailand.

Fanny Petermann-Rocha (F)

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; Centro de Investigación Biomédica, Facultad de Medicina, Universidad Diego Portales, Santiago, Chile.

Paul Welsh (P)

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

Patrick B Mark (PB)

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

Naveed Sattar (N)

School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.

Jill P Pell (JP)

School of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Carlos Celis-Morales (C)

School of Health and Wellbeing, University of Glasgow, Glasgow, UK; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; Education, Physical Activity and Health Research Unit, Universidad Catolica del Maule, Talca, Chile.

Frederick K Ho (FK)

School of Health and Wellbeing, University of Glasgow, Glasgow, UK. Electronic address: Frederick.Ho@glasgow.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH